Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database | Synapse
March 20, 2024Open Access
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Oral anticoagulants (OACs) are recommended for patients with atrial fibrillation (AFib) having CHA